EcoDrugPlus

Arginine Vasopressin Receptor 2

Ensembl ID : ENSACIG00000004629
Gene Symbol: AVPR2
2 Cross references
166 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSACIG00000015943
Gene Symbol: AURKA
1 Cross references
230 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSACIG00000021291
Gene Symbol: AURKA
1 Cross references
211 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSACIG00000003527
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSACIG00000012485
Gene Symbol: BACE1
2 Cross references
221 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSACIG00000014824
Gene Symbol: BDKRB1
1 Cross references
149 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSACIG00000014963
Gene Symbol: BDKRB2
1 Cross references
235 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSACIG00000014833
Gene Symbol: BDKRB2
2 Cross references
235 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSACIG00000014864
Gene Symbol: BDKRB2
2 Cross references
216 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSACIG00000014919
Gene Symbol: BDKRB2
2 Cross references
235 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSACIG00000018635
Gene Symbol: CACNA1C
1 Cross references
215 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSACIG00000019013
Gene Symbol: CACNA1DA
1 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).